Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage
Shipping and logistics companies are tapping into the growing market of healthcare as cold chain and temperature-controlled facilities become more crucial.
As specialized medications like GLP-1s surge in demand, logistics firms like UPS and FedEx are stepping up their approaches to more efficiently transport and store these pharmaceuticals. Refrigerated storage is essential for most injectable GLP-1 drugs, including Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro and Zepbound.
The COVID-19 pandemic amplified the significance of healthcare logistics, particularly the shipping of temperature-controlled vaccines. Consequently, logistics companies are capitalizing on this trend by investing heavily in temperature-controlled facilities. UPS recently announced a $48 million investment, recognizing a growing demand for critical treatments.
